Posted, 13 October 2025

Strengthening Bones & Joints this October — The Role of NEM®

October Spotlight: Supporting Joint Health with NEM® Eggshell Membrane

October is Bone & Joint Health Awareness Month, a time to shine a light on the importance of musculoskeletal health and how we can proactively support it. Healthy bones and joints underpin mobility, quality of life, and independence as we age.

This year, as the UK exclusive distributor via Sibelius Natural Products, we’re proud to promote NEM® a clinically studied eggshell membrane ingredient developed by Stratum Nutrition as a compelling option for joint health formulas.

Why Bone & Joint Health Matters

Bone and joint / musculoskeletal conditions are among the leading causes of disability and work absence globally.
Conditions like osteoarthritis, cartilage degradation, joint stiffness, and inflammation affect millions, reducing mobility and quality of life.
Bone & Joint Week (often mid-October) complements this awareness month, promoting education, prevention, and early action.
Healthy bones and joints allow us to stay active, avoid pain, and maintain independence as we age.

Thus, formulators and supplement brands should seek ingredients that are safe, evidence-based, and consumer-friendly to support joint health.

What is NEM®?

NEM® (Eggshell Membrane) is a partially hydrolysed eggshell membrane ingredient formulated to deliver joint and cartilage supportive components.

Key facts:

It originates from the inner lining of chicken eggshells, which naturally contains collagen, glycosaminoglycans (GAGs), hyaluronic acid, chondroitin, and sulfur-containing peptides.
Partial hydrolysis (a gentle enzymatic process) helps “unlock” the beneficial components, making them more bioavailable even in individuals with less efficient digestion.
It is sustainably sourced from renewable eggshell waste (an upcycled ingredient).
NEM® is Stratum’s flagship joint health ingredient and is now distributed in the UK exclusively by Sibelius.

Clinical Evidence & Benefits

Over 16 clinical studies (involving over 1,000 participants) support NEM®’s safety and efficacy in joint support, particularly in reducing joint pain, stiffness, and supporting cartilage.
Effects have been observed in as few as 4 to 11 days in many individuals.
In a recent trial, participants who took NEM® while undergoing exercise reported less exercise-induced joint pain and stiffness, and markers of cartilage degradation (CTX-II) were meaningfully suppressed.

These outcomes make NEM® a compelling candidate for joint health formulations that want fast-acting, evidence-backed effects.

This October, as we recognise Bone & Joint Awareness Month, let’s build formulations that truly support musculoskeletal health. If you are exploring or updating a joint health formula, consider NEM® for its rich scientific foundation and sustainable sourcing.